FDA Adverse Event Injury Summary report: N

DV8 ESOPHAGEAL RETRACTOR

MDR report key: 7054650 · Received November 22, 2017

Report

Report Number
3011596926-2017-00002
Event Type
Injury
Date Received
November 22, 2017
Date of Event
October 25, 2016
Report Date
November 22, 2017
Manufacturer
MANUAL SURGICAL SCIENCES, LLC
Product Code
GAD
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ADDITIONAL INFORMATION: THE DV8 RETRACTOR IS A CLASS I 510K EXEMPT DEVICE UNDER PRODUCT CODE GAD (RETRACTOR) WHICH FALLS UNDER REGULATION 21 CFR 878.4800 AS A "MANUAL SURGICAL INSTRUMENT FOR GENERAL USE."

Description of Event or Problem · 1

IT WAS REPORTED THAT UPON COMPLETION OF A PVI PROCEDURE WITH GENERAL ANESTHESIA ON (B)(6) 2016, THE PATIENT EXPERIENCED BLEEDING. THE DV8 DEVICE WAS EMPLOYED TO LATERALLY DISPLACE THE ESOPHAGUS, HOWEVER, ESOPHAGEAL INTUBATION WAS REPORTEDLY DIFFICULT. IMMEDIATELY POST PROCEDURE, PRIOR TO EXTUBATION, THERE WAS BLOOD NOTED IN THE OROPHARYNX. THE HOSPITAL GASTROINTESTINAL DEPARTMENT WAS CONSULTED, AND AN ESOPHAGOGASTRODUODENOSCOPY (EGD) WAS PERFORMED. NO ABNORMALITIES OR BLEEDING WERE IDENTIFIED, BUT 2 CM PROXIMAL TO THE UPPER ESOPHAGEAL SPHINCTER, THERE WAS A SMALL HEMATOMA WITH NO ACTIVE BLEEDING. THE HOSPITAL EAR NOSE AND THROAT DEPARTMENT WAS ALSO CONSULTED, AND A FLEXIBLE LARYNGOSCOPY AND DIRECT LARYNGOSCOPY WERE BOTH PERFORMED. THIS REVEALED A SMALL (1.5-2 CM) LINEAR LACERATION SEEN AT MIDLINE IN THE POSTERIOR OROPHARYNX WITH SLOW ACTIVE BLEEDING CONTROLLED WITH SILVER NITRATE AND SURGICEL. THE SURGICEL WAS REMOVED WITH NO PACKING LEFT AND HEMOSTATIS WAS OBTAINED. THE PATIENT REMAINED INTUBATED FOR 2 DAYS, AND WAS EXTUBATED WITH PERIDEX ORAL RINSES THREE TIMES DAILY (INTUBATION WAS PARTLY DUE TO THE PRE-EXISTING LUNG DISEASE, PER THE PHYSICIAN). THE HOSPITALIZATION COURSE WAS COMPLICATED BY CHOLECYSTITIS, AND THE PATIENT REQUIRED A LAPAROSCOPIC CHOLECYSTECTOMY WITHOUT COMPLICATION ON THE 7TH POST-OPERATIVE DAY. THE PATIENT ALSO EXPERIENCED THROMBOCYTOPENIA AND A PULMONARY EMBOLISM ON THE 10TH POST-OPERATIVE DAY (RELATED TO HEPARIN INDUCED THROMBOCYTOPENIA). THE PATIENT WAS TREATED WITH IV ARGATROBAN UNTIL THE WARFARIN REACHED AN INR GREATER THAN 2. THE PATIENT WAS DISCHARGED 17 DAYS POST PROCEDURE. THE PATIENT WAS SEEN IN THE CLINIC FOR FOLLOW UP 11 DAYS LATER AND HAD NO THROAT OR NECK DISCOMFORT AND ALL SYMPTOMS HAD RESOLVED. IF ADDITIONAL INFORMATION IS PROVIDED, A FOLLOW UP REPORT WILL BE SENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
831489 DV8 ESOPHAGEAL RETRACTOR DV8 RETRACTOR GAD MANUAL SURGICAL SCIENCES, LLC 14075150

Patients

Seq Age Sex Outcome Treatment
1 75 YR Hospitalization| R